Knockdown or inhibition of LIMK1 inhibits the proliferation of lung cancer, gastric cancer, colorectal cancer (CRC), and acute myeloid leukaemia (AML) cells, as well as the invasion motility of glioblastoma11,12,.18–20. The gene discussed is LIMK1; the disease is colorectal cancer.